PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: EAP treatment completed and Orphan Status achieved for MPS-I, page-18

  1. 5,036 Posts.
    lightbulb Created with Sketch. 660
    I will hold till the last results in the Q3 ,then hopefully see from there
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.